ID   RAGE_RAT                Reviewed;         402 AA.
AC   Q63495;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-OCT-2024, entry version 154.
DE   RecName: Full=Advanced glycosylation end product-specific receptor;
DE   AltName: Full=Receptor for advanced glycosylation end products;
DE   Flags: Precursor;
GN   Name=Ager; Synonyms=Rage;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=9224812; DOI=10.1124/mol.52.1.54;
RA   Renard C., Chappey O., Wautier M.P., Nagashima M., Lundh E., Morser J.,
RA   Zhao L., Schmidt A.M., Scherrmann J.M., Wautier J.-L.;
RT   "Recombinant advanced glycation end product receptor pharmacokinetics in
RT   normal and diabetic rats.";
RL   Mol. Pharmacol. 52:54-62(1997).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH S100B AND S100A1,
RP   INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19910580; DOI=10.1161/circresaha.109.195834;
RA   Tsoporis J.N., Izhar S., Leong-Poi H., Desjardins J.F., Huttunen H.J.,
RA   Parker T.G.;
RT   "S100B interaction with the receptor for advanced glycation end products
RT   (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis
RT   postinfarction.";
RL   Circ. Res. 106:93-101(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376 AND SER-389, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=28627626; DOI=10.3892/mmr.2017.6772;
RA   Xie Y., Yu N., Chen Y., Zhang K., Ma H.Y., Di Q.;
RT   "HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains
RT   via the RAGE/NF-kappaB signaling pathway.";
RL   Mol. Med. Report. 16:1691-1700(2017).
CC   -!- FUNCTION: Cell surface pattern recognition receptor that senses
CC       endogenous stress signals with a broad ligand repertoire including
CC       advanced glycation end products, S100 proteins, high-mobility group box
CC       1 protein/HMGB1, amyloid beta/APP oligomers, nucleic acids,
CC       phospholipids and glycosaminoglycans (PubMed:19910580,
CC       PubMed:28627626). Advanced glycosylation end products are
CC       nonenzymatically glycosylated proteins which accumulate in vascular
CC       tissue in aging and at an accelerated rate in diabetes. These ligands
CC       accumulate at inflammatory sites during the pathogenesis of various
CC       diseases, including diabetes, vascular complications, neurodegenerative
CC       disorders, and cancers and RAGE transduces their binding into pro-
CC       inflammatory responses. Upon ligand binding, uses TIRAP and MYD88 as
CC       adapters to transduce the signal ultimately leading to the induction or
CC       inflammatory cytokines IL6, IL8 and TNFalpha through activation of NF-
CC       kappa-B. Interaction with S100A12 on endothelium, mononuclear
CC       phagocytes, and lymphocytes triggers cellular activation, with
CC       generation of key pro-inflammatory mediators (By similarity).
CC       Interaction with S100B after myocardial infarction may play a role in
CC       myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By
CC       similarity). Contributes to the translocation of amyloid-beta peptide
CC       (ABPP) across the cell membrane from the extracellular to the
CC       intracellular space in cortical neurons. ABPP-initiated RAGE signaling,
CC       especially stimulation of p38 mitogen-activated protein kinase (MAPK),
CC       has the capacity to drive a transport system delivering ABPP as a
CC       complex with RAGE to the intraneuronal space. Participates in
CC       endothelial albumin transcytosis together with HMGB1 through the
CC       RAGE/SRC/Caveolin-1 pathway, leading to endothelial hyperpermeability.
CC       Mediates the loading of HMGB1 in extracellular vesicles (EVs) that
CC       shuttle HMGB1 to hepatocytes by transferrin-mediated endocytosis and
CC       subsequently promote hepatocyte pyroptosis by activating the NLRP3
CC       inflammasome. Promotes also extracellular hypomethylated DNA (CpG DNA)
CC       uptake by cells via the endosomal route to activate inflammatory
CC       responses (By similarity). {ECO:0000250|UniProtKB:Q15109,
CC       ECO:0000250|UniProtKB:Q62151, ECO:0000269|PubMed:19910580,
CC       ECO:0000269|PubMed:28627626}.
CC   -!- SUBUNIT: Constitutive homodimer; disulfide-linked. Forms homooligomers
CC       (By similarity). Interacts with S100A1 and APP (By similarity).
CC       Interacts with S100B, S100A12 and S100A14. Interacts with TIRAP.
CC       Interacts with HMGB1 (By similarity). Interacts with LGP2; this
CC       interaction plays an important role in AGER-mediated pro-inflammatory
CC       responses and cytokine release (By similarity).
CC       {ECO:0000250|UniProtKB:Q15109, ECO:0000250|UniProtKB:Q62151}.
CC   -!- INTERACTION:
CC       Q63495; P04631: S100b; NbExp=3; IntAct=EBI-6479195, EBI-2696631;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19910580}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:19910580}.
CC   -!- TISSUE SPECIFICITY: Endothelial cells and cardiomyocytes
CC       (PubMed:19910580). Expressed in brain (PubMed:28627626).
CC       {ECO:0000269|PubMed:19910580, ECO:0000269|PubMed:28627626}.
CC   -!- INDUCTION: Up-regulated in periinfarct ventricular myocardium.
CC       {ECO:0000269|PubMed:19910580}.
CC   -!- PTM: Phosphorylated on its cytoplasmic domain by PKCzeta/PRKCZ upon
CC       ligand binding. {ECO:0000250|UniProtKB:Q15109}.
CC   -!- PTM: Targeted by the ubiquitin E3 ligase subunit FBXO10 to mediate its
CC       ubiquitination and degradation. {ECO:0000250|UniProtKB:Q15109}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L33413; AAA42027.1; -; mRNA.
DR   AlphaFoldDB; Q63495; -.
DR   SMR; Q63495; -.
DR   IntAct; Q63495; 2.
DR   STRING; 10116.ENSRNOP00000000508; -.
DR   BindingDB; Q63495; -.
DR   ChEMBL; CHEMBL2176847; -.
DR   GlyCosmos; Q63495; 2 sites, No reported glycans.
DR   GlyGen; Q63495; 2 sites.
DR   iPTMnet; Q63495; -.
DR   PhosphoSitePlus; Q63495; -.
DR   PaxDb; 10116-ENSRNOP00000000508; -.
DR   UCSC; RGD:69258; rat.
DR   AGR; RGD:69258; -.
DR   RGD; 69258; Ager.
DR   eggNOG; ENOG502SQ8N; Eukaryota.
DR   InParanoid; Q63495; -.
DR   PhylomeDB; Q63495; -.
DR   Reactome; R-RNO-445989; TAK1-dependent IKK and NF-kappa-B activation.
DR   Reactome; R-RNO-879415; Advanced glycosylation endproduct receptor signaling.
DR   Reactome; R-RNO-933542; TRAF6 mediated NF-kB activation.
DR   PRO; PR:Q63495; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0070379; F:high mobility group box 1 binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005055; F:laminin receptor activity; IBA:GO_Central.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0044548; F:S100 protein binding; IPI:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; ISO:RGD.
DR   GO; GO:0048143; P:astrocyte activation; ISO:RGD.
DR   GO; GO:0014002; P:astrocyte development; ISO:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IMP:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0010255; P:glucose mediated signaling pathway; ISO:RGD.
DR   GO; GO:0009100; P:glycoprotein metabolic process; IEP:RGD.
DR   GO; GO:0050930; P:induction of positive chemotaxis; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0001774; P:microglial cell activation; ISO:RGD.
DR   GO; GO:1903523; P:negative regulation of blood circulation; ISO:RGD.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IMP:RGD.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IMP:RGD.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; IMP:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:RGD.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; ISO:RGD.
DR   GO; GO:1900453; P:negative regulation of long-term synaptic depression; ISO:RGD.
DR   GO; GO:1900272; P:negative regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0033689; P:negative regulation of osteoblast proliferation; IEP:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:2001200; P:positive regulation of dendritic cell differentiation; ISO:RGD.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; IMP:RGD.
DR   GO; GO:1904472; P:positive regulation of endothelin production; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; IMP:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; ISO:RGD.
DR   GO; GO:2000439; P:positive regulation of monocyte extravasation; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; IMP:RGD.
DR   GO; GO:0072657; P:protein localization to membrane; ISO:RGD.
DR   GO; GO:2000514; P:regulation of CD4-positive, alpha-beta T cell activation; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:1900744; P:regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:0150003; P:regulation of spontaneous synaptic transmission; ISO:RGD.
DR   GO; GO:0001914; P:regulation of T cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0009750; P:response to fructose; IEP:RGD.
DR   GO; GO:0033595; P:response to genistein; IEP:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0051595; P:response to methylglyoxal; IEP:RGD.
DR   GO; GO:0072714; P:response to selenite ion; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0045056; P:transcytosis; ISO:RGD.
DR   GO; GO:0060290; P:transdifferentiation; IEP:RGD.
DR   GO; GO:0150104; P:transport across blood-brain barrier; ISO:RGD.
DR   CDD; cd00096; Ig; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR051116; Surface_Rcpt/Adhesion_Mol.
DR   PANTHER; PTHR11973:SF20; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; 1.
DR   PANTHER; PTHR11973; CELL SURFACE GLYCOPROTEIN MUC18-RELATED; 1.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Inflammatory response;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..402
FT                   /note="Advanced glycosylation end product-specific
FT                   receptor"
FT                   /id="PRO_0000014925"
FT   TOPO_DOM        23..341
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        342..362
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        363..402
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          23..109
FT                   /note="Ig-like V-type"
FT   DOMAIN          123..219
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          233..315
FT                   /note="Ig-like C2-type 2"
FT   REGION          368..402
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        25
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        38..98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        143..206
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        257
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        299
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   402 AA;  42664 MW;  594481BC3A51E94E CRC64;
     MPTGTVARAW VLVLALWGAV AGGQNITARI GEPLMLSCKG APKKPTQKLE WKLNTGRTEA
     WKVLSPQGDP WDSVARILPN GSLLLPAIGI VDEGTFRCRA TNRLGKEVKS NYRVRVYQIP
     GKPEIVNPAS ELTANVPNKV GTCVSEGSYP AGTLSWHLDG KPLIPDGKGT VVKEETRRHP
     ETGLFTLRSE LTVTPAQGGT TPTYSCSFSL GLPRRRPLNT APIQPRVREP LPPEGIQLLV
     EPEGGTVAPG GTVTLTCAIS AQPPPQIHWI KDGTPLPLAP SPVLLLPEVG HEDEGIYSCV
     ATHPSHGPQE SPPVNIRVTE TGDEGQAAGS VDGSGLGTLA LALGILGGLG IAALLIGAIL
     WRKRQPRLEE RKAPESQEDE EERAELNQSE EAEMPENGAG GP
//
